Targeting neuropilin-1 in human leukemia and lymphoma
- 20 January 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (3), 920-927
- https://doi.org/10.1182/blood-2010-05-282921
Abstract
Targeted drug delivery offers an opportunity for the development of safer and more effective therapies for the treatment of cancer. In this study, we sought to identify short, cell-internalizing peptide ligands that could serve as directive agents for specific drug delivery in hematologic malignancies. By screening of human leukemia cells with a combinatorial phage display peptide library, we isolated a peptide motif, sequence Phe-Phe/Tyr-Any-Leu-Arg-Ser (FF/YXLRS), which bound to different leukemia cell lines and to patient-derived bone marrow samples. The motif was internalized through a receptor-mediated pathway, and we next identified the corresponding receptor as the transmembrane glycoprotein neuropilin-1 (NRP-1). Moreover, we observed a potent anti-leukemia cell effect when the targeting motif was synthesized in tandem to the pro-apoptotic sequence D(KLAKLAK)2. Finally, our results confirmed increased expression of NRP-1 in representative human leukemia and lymphoma cell lines and in a panel of bone marrow specimens obtained from patients with acute lymphoblastic leukemia or acute myelogenous leukemia compared with normal bone marrow. These results indicate that NRP-1 could potentially be used as a target for ligand-directed therapy in human leukemias and lymphomas and that the prototype CGFYWLRSC-GG-D(KLAKLAK)2 is a promising drug candidate in this setting.Keywords
This publication has 52 references indexed in Scilit:
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer DrugsScience, 2010
- From combinatorial peptide selection to drug prototype (I): Targeting the vascular endothelial growth factor receptor pathwayProceedings of the National Academy of Sciences, 2010
- Role of leukemia cell invadosome in extramedullary infiltrationBlood, 2009
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProceedings of the National Academy of Sciences, 2009
- Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approachesDrug Resistance Updates, 2009
- Neuropilins in neoplasms: Expression, regulation, and functionExperimental Cell Research, 2006
- Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide LibrariesCancer Research, 2006
- A Novel Role for Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Embryonic Stem Cells during HypoxiaJournal of Biological Chemistry, 2005
- A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune responseNature Immunology, 2002
- Neuropilin-1 Participates in Wound AngiogenesisThe American Journal of Pathology, 2002